Success Stories: Nepalese Teaching Associate and Technical Sales Specialist in Microbiology Earns EB2-NIW Approval

Client’s Testimonial:

“Thank you for your help throughout the process.”

On April 5^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Teaching Associate and Technical Sales Specialist in the Field of Microbiology (Approval Notice).

General Field: Microbiology

Position at the Time of Case Filing: Teaching Associate and Technical Sales Specialist

Country of Origin: Nepal

Country of Residence at the Time of Filing: Australia

Approval Notice Date: April 5^th, 2025

Processing Time: 1 year and 4 months

Case Summary:

A Teaching Associate and Technical Sales Specialist from Nepal, with a Ph.D. in biochemistry and molecular biology, contacted our law firm for assistance in filing an EB-2 NIW (National Interest Waiver) petition. With a specialized research background in combating antibiotic-resistant bacterial infections, we built a petition strategy that emphasized the national relevance of his proposed endeavor and the strength of his scientific credentials.

His proposed work focuses on developing vaccines through advanced molecular biology and immunological approaches to address bacterial pathogens that have become resistant to standard antibiotic treatments. One of his primary research targets is Neisseria gonorrhoeae, a sexually transmitted bacterium now considered a major antimicrobial resistance threat in the U.S. due to its rapid evolution against multiple lines of treatment.

This work directly aligns with urgent national health priorities. Antimicrobial resistance is responsible for millions of infections and tens of thousands of deaths each year in the United States. By contributing novel strategies for vaccine design, the client’s work offers significant potential to reduce the disease burden, improve treatment outcomes, and lower long-term healthcare costs.

To demonstrate his qualifications to advance this vital research, we emphasized the following accomplishments:

● Authored nine peer-reviewed scientific articles, including five as first or co-first author, published in high-impact journals such as Nature Microbiology, PLOS Pathogens, and Trends in Microbiology
● Contributed to one preprint and four research abstracts, showcasing active scholarly output
● Received 362 citations, highlighting the broad recognition of his work
● Six publications ranked among the top 10–20% most-cited microbiology articles for their respective years
● Received research funding support from the National Health and Medical Research Council (NHMRC) of Australia, an organization that funds work with major implications for public health

His contributions have advanced knowledge in bacterial outer membrane vesicles (OMVs), host-pathogen interactions, and inflammation signaling—all foundational to new vaccine platforms. His work has not only influenced the academic community but also supports innovation in public health strategies and infectious disease prevention.

Our filing included a comprehensive presentation of his academic history, research accomplishments, and national relevance of the proposed endeavor.

His I-140 NIW petition was ultimately approved by USCIS in 1 year and 4 months, and notably, no Request for Evidence was issued during adjudication. We are proud to have contributed to this successful outcome and look forward to his continued success.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.